Literature DB >> 18683041

The economic burden of breast cancer in California.

Wendy Max1, Hai-Yen Sung, Brad Stark.   

Abstract

This paper estimates the healthcare costs and the value of lost productivity from premature deaths for California women with breast cancer in 2001, with an updated estimate for 2008. Multiple secondary data sources were used to estimate the healthcare cost of breast cancer. Mortality costs were estimated as the product of the number of deaths and the expected value of a woman's future earnings. The total economic cost of breast cancer in California was $1.43 billion in 2001, or $1.91 billion in 2008 dollars. Breast cancer is costly both in terms of healthcare dollars and the value of lost lives. Regular screening and access to treatment for all women will allow the disease to be diagnosed earlier, the prognosis improved, and the economic burden reduced.

Entities:  

Mesh:

Year:  2008        PMID: 18683041     DOI: 10.1007/s10549-008-0149-4

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  13 in total

1.  Economic burden of cancer survivorship among adults in the United States.

Authors:  Gery P Guy; Donatus U Ekwueme; K Robin Yabroff; Emily C Dowling; Chunyu Li; Juan L Rodriguez; Janet S de Moor; Katherine S Virgo
Journal:  J Clin Oncol       Date:  2013-09-16       Impact factor: 44.544

2.  Health and economic impact of breast cancer mortality in young women, 1970-2008.

Authors:  Donatus U Ekwueme; Gery P Guy; Sun Hee Rim; Arica White; Ingrid J Hall; Temeika L Fairley; Hazel D Dean
Journal:  Am J Prev Med       Date:  2014-01       Impact factor: 5.043

3.  Healthcare costs in women with metastatic breast cancer receiving chemotherapy as their principal treatment modality.

Authors:  Montserrat Vera-Llonch; Derek Weycker; Andrew Glass; Sue Gao; Rohit Borker; Angie Qin; Gerry Oster
Journal:  BMC Cancer       Date:  2011-06-15       Impact factor: 4.430

4.  Pharmacoeconomic considerations in the treatment of breast cancer.

Authors:  Athanasios Pallis; Vasiliki Tsiantou; Efi Simou; Nikos Maniadakis
Journal:  Clinicoecon Outcomes Res       Date:  2010-06-15

5.  Determining Breast Cancer Treatment Costs Using the Top Down Cost Approach.

Authors:  Rukiye Numanoğlu Tekin; Meltem Saygılı
Journal:  Eur J Breast Health       Date:  2019-10-01

6.  Breast cancer attributable costs in Germany: a top-down approach based on sickness funds data.

Authors:  Emil Victor Gruber; Stephanie Stock; Björn Stollenwerk
Journal:  PLoS One       Date:  2012-12-10       Impact factor: 3.240

7.  Organizing medical oncology care at a regional level and its subsequent impact on the quality of early breast cancer management: a before-after study.

Authors:  Aline Voidey; Xavier Pivot; Anne-Sophie Woronoff; Gilles Nallet; Laurent Cals; Francis Schwetterle; Samuel Limat
Journal:  BMC Health Serv Res       Date:  2014-07-28       Impact factor: 2.655

8.  The Economic Burden of Breast Cancer in Iran.

Authors:  Rajabali Daroudi; Ali Akbari Sari; Azin Nahvijou; Bita Kalaghchi; Massoomeh Najafi; Kazem Zendehdel
Journal:  Iran J Public Health       Date:  2015-09       Impact factor: 1.429

9.  The Productivity Costs of Premature Mortality Due to Cancer in Australia: Evidence from a Microsimulation Model.

Authors:  Hannah E Carter; Deborah J Schofield; Rupendra Shrestha
Journal:  PLoS One       Date:  2016-12-12       Impact factor: 3.240

10.  Productivity losses and public finance burden attributable to breast cancer in Poland, 2010-2014.

Authors:  Błażej Łyszczarz; Ewelina Nojszewska
Journal:  BMC Cancer       Date:  2017-10-10       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.